Advertisement

Topics

Alzheon Inc. Company Profile

07:51 EST 13th December 2018 | BioPortfolio

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clinical candidate, ALZ-801, is a first-in-class, oral inhibitor of amyloid aggregation and neurotoxicity - hallmarks of Alzheimer’s disease. ALZ-801 is an optimized, novel prodrug that builds on the established safety and efficacy profile of the active compound in clinical trials of more than 2,000 patients. Our mission is to apply our discovery platform and development experience to unlock new classes of therapeutics that make a difference in patients’ lives by directly addressing the underlying pathology of devastating neurodegenerative disorders. www.alzheon.com.


News Articles [19 Associated News Articles listed on BioPortfolio]

Alzheon finds brain substance inhibits Alzheimer’s protein formation

Biopharmaceutical firm Alzheon has discovered an endogenous substance in the human brain that can block the formation of neurotoxic beta...Read More... The post Alzheon finds brain substance inhibits ...

Alzheon Takes Another Shot at an IPO

In April, Alzheon attempted an initial public offering (IPO) to raise $80 million, but withdrew the offering. It has decided to try again, filing with the U.S. Securities and Exchange Commission (SEC)...

Alzheon Researchers Identify Brain Molecule that Inhibits Formation of Alzheimer’s Proteins

Scientists with Framingham, Massachusetts-based Alzheon identified a substance in the human brain that inhibits the formation of beta-amyloid, the primary driver of Alzheimer’s disease. The substanc...

Alzheon Scientists Discover Endogenous Substance in Human Brain that Inhibits Formation of Key Driver of Alzheimer’s Disease

FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and ...

Alzheon Presents New Findings in APOE4/4 Homozygous Patients with Mild Alzheimer’s Disease and Planned Confirmatory Clinical Trial with ALZ-801

FRAMINGHAM, Mass.–(BUSINESS WIRE)–Alzheon, Inc., a clinical-stage biopharmaceutical company focused on developing new medicines for patients suffering from Alzheimer’s disease (AD) and ...

Alzheon proposes new IPO seeking $41.2M

Alzheon Proposes Terms For Smaller IPO

Alzheon Files Revised IPO Statement For $40 Million

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [2 Associated Companies listed on BioPortfolio]

Alzheon, Inc.

Alzheon, Inc., is a clinical-stage biotechnology company focused on brain health, memory and aging, developing innovative treatments for Alzheimer’s disease and other neurode...

Alzheon Inc.

Alzheon, Inc. is committed to developing innovative medicines for patients suffering from Alzheimer’s disease and other neurological and psychiatric disorders. Our lead clini...

More Information about "Alzheon Inc." on BioPortfolio

We have published hundreds of Alzheon Inc. news stories on BioPortfolio along with dozens of Alzheon Inc. Clinical Trials and PubMed Articles about Alzheon Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Alzheon Inc. Companies in our database. You can also find out about relevant Alzheon Inc. Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Alzheimer's Disease
Of all the types of Dementia, Alzheimer's disease is the most common, affecting around 465,000 people in the UK. Neurons in the brain die, becuase  'plaques' and 'tangles' (mis-folded proteins) form in the brain. People with Al...

Psychiatry
Psychiatry is the study of mental disorders and their diagnosis, management and prevention.  Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...


Corporate Database Quicklinks



Searches Linking to this Company Record